News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Federal judge blocks $400M White House ballroom construction with a preliminary injunction, pausing the project pending litigation over executive authority.
  • Analysts recommend buying Unity Bancorp and Northrim, citing attractive valuations and dividends, signaling renewed investor interest in regional banks.
  • Amnesty warns 2026 World Cup fans face mass deportation, strict policing, and displacement risks in U.S., Mexico, and Canada.
  • White House says U.S. forces are prepared to deter Iranian strikes after IRGC threats, increasing risk to American firms operating regionally.
  • State Department directs diplomats to use X and coordinate with Pentagon psyops to expose foreign influence online.

Latest Articles

Dime CEO Sells $878K in Stock Amid Strong Quarter; Form 4 Filed

Dime CEO Sells $878K in Stock Amid Strong Quarter; Form 4 Filed

Stuart H. Lubow, president and CEO of Dime Community Bancshares (NASDAQ: DCOM), sold 25,026 shares of the bank's common stock across two transactions on February 12 and 13, 2026, totaling roughly $878,104. The trades were reported on a Form 4 filed with the SEC. The company recently reported stronger-than-expected fourth-quarter 2025 results and sa…

Buy the Panic: Why Amazon at $200 Is a Tactical Long

Buy the Panic: Why Amazon at $200 Is a Tactical Long

Amazon just retraced to $200 after a sell-off that erased a year of gains. Fundamentals still show a dominant AWS margin engine, healthy returns on equity, and a fortress-like balance sheet. The market is pricing in prolonged weakness; we view today's drop as a tactical buying opportunity with defined risk and a clear target: get long on a measured…

EQT and Vitruvian Weigh Sale or IPO for Cyber Insurer CFC

EQT and Vitruvian Weigh Sale or IPO for Cyber Insurer CFC

EQT AB and Vitruvian Partners have engaged financial advisers to explore strategic options for their investment in cyber insurer CFC, including a potential sale or an initial public offering. Evercore Inc. and Goldman Sachs Group Inc. have been retained to prepare CFC for these alternatives. A transaction could value the company at about £5 billion…

Horizon Kinetics Reports One-Share Purchase of Texas Pacific Land; TPL Advances Data Center Partnership and Sets Stock Split Dates

Horizon Kinetics Reports One-Share Purchase of Texas Pacific Land; TPL Advances Data Center Partnership and Sets Stock Split Dates

Horizon Kinetics Asset Management LLC, a roughly 10% shareholder in Texas Pacific Land Corp (TPL), reported acquiring a single share of common stock on February 13, 2026, at $426.38, with a reported transaction value of $426. After the trade, Horizon Kinetics directly holds 3,479,373 shares. Separately, TPL announced a strategic partnership with Bo…

SEC Chair Signals Move to Narrow Executive Pay Disclosures

SEC Chair Signals Move to Narrow Executive Pay Disclosures

The chair of the U.S. Securities and Exchange Commission indicated regulators are considering limiting which senior executives must be included in detailed investor disclosures about compensation. The proposals, part of a wider agenda to ease compliance burdens on public companies, could also simplify pay-versus-performance metrics and change repor…

DA Davidson Lifts PDF Solutions Price Target Citing Strong Revenue Momentum

DA Davidson Lifts PDF Solutions Price Target Citing Strong Revenue Momentum

DA Davidson has increased its price target for PDF Solutions Inc. (NASDAQ: PDFS) to $38 from $36 while retaining a Buy recommendation, a move tied to stronger-than-expected fourth-quarter 2025 revenue and an optimistic 2026 revenue outlook. The new target implies roughly 16% upside from the stock's current price of $32.84. The firm’s valuation assu…

Truist Lowers Neurocrine Price Target Citing Larger-Than-Expected Spending

Truist Lowers Neurocrine Price Target Citing Larger-Than-Expected Spending

Truist Securities trimmed its price target on Neurocrine Biosciences to $140 from $169 while retaining a Buy rating after updating its model to reflect higher operating expenses following the company's fourth-quarter 2025 results and 2026 guidance. The adjustment follows management's projection of materially increased spending, particularly in rese…